Check out the most important news stories, which captured the headlines at the corporate level in India and internationally.
Cadila Healthcare said that it has received the final approval from the US drug regulator to market an anti-viral drug Acyclovir capsules (200 mg).
Ashok Leyland has won orders valued at Rs8bn from the Indian armed forces. The company will supply Field artillery tractor, super stallion vehicles and ambulance.
Lupin has received a total of three observations relating to violationof production norms at manufacturing facilities at Mandideep, Madhya Pradesh from the US Food and Drug Administration.
Reliance Defence Ltd, a 100% subsidiary of Reliance Infrastructure Ltd, and Rafael Advanced Defence Systems Ltd have decided to set up a joint venture (JV) company in India in the areas of air-to-air missiles, air defence systems and large aerostats.
Sadbhav Infrastructure Project has been awarded "L1" status for road projects from National Highways Authority of India. The first is the four laning and design chainage of Rampur-Kathgodam section of NH-87 in the State of Uttar Pradesh under NHDP-III on hybrid annuity mode.
Aurobindo Pharma Limited has received final approval from the US Food and Drug Administration to manufacture and market rivastigmine tartrate capsules USP in 1.5 mg, 3 mg, 4.5 mg and 6 mg strengths.
Bank of India said the government has approved a capital infusion of Rs11.5bn in lieu of preferential allotment of shares.
Adani Ports and special economic zone said it has raised Rs5bn through issue of debentures on private placement basis.
GlaxoSmithKline Pharmaceuticals Ltd is looking at launching two or three combination vaccines in India in the near future, to address a host of paediatric disease.
Alembic Pharmaceuticals, is likely to receive some minor observations (as a Form 483) from the US drug regulator for its Panelav facility.
Ashok Leyland has won orders valued at Rs8bn from the Indian armed forces. The company will supply Field artillery tractor, super stallion vehicles and ambulance.
Lupin has received a total of three observations relating to violationof production norms at manufacturing facilities at Mandideep, Madhya Pradesh from the US Food and Drug Administration.
Reliance Defence Ltd, a 100% subsidiary of Reliance Infrastructure Ltd, and Rafael Advanced Defence Systems Ltd have decided to set up a joint venture (JV) company in India in the areas of air-to-air missiles, air defence systems and large aerostats.
Sadbhav Infrastructure Project has been awarded "L1" status for road projects from National Highways Authority of India. The first is the four laning and design chainage of Rampur-Kathgodam section of NH-87 in the State of Uttar Pradesh under NHDP-III on hybrid annuity mode.
Aurobindo Pharma Limited has received final approval from the US Food and Drug Administration to manufacture and market rivastigmine tartrate capsules USP in 1.5 mg, 3 mg, 4.5 mg and 6 mg strengths.
Bank of India said the government has approved a capital infusion of Rs11.5bn in lieu of preferential allotment of shares.
Adani Ports and special economic zone said it has raised Rs5bn through issue of debentures on private placement basis.
GlaxoSmithKline Pharmaceuticals Ltd is looking at launching two or three combination vaccines in India in the near future, to address a host of paediatric disease.
Alembic Pharmaceuticals, is likely to receive some minor observations (as a Form 483) from the US drug regulator for its Panelav facility.
No comments:
Post a Comment